These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 20639794)
1. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ Pediatr Res; 2010 Nov; 68(5):419-22. PubMed ID: 20639794 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ Brain Behav Immun; 2010 Mar; 24(3):387-93. PubMed ID: 19883750 [TBL] [Abstract][Full Text] [Related]
3. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Donega V; Nijboer CH; van Tilborg G; Dijkhuizen RM; Kavelaars A; Heijnen CJ Exp Neurol; 2014 Nov; 261():53-64. PubMed ID: 24945601 [TBL] [Abstract][Full Text] [Related]
4. CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain. Hermans EC; Donega V; Heijnen CJ; de Theije CGM; Nijboer CH Stem Cell Res Ther; 2024 May; 15(1):134. PubMed ID: 38715091 [TBL] [Abstract][Full Text] [Related]
5. Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Donega V; Nijboer CH; van Velthoven CT; Youssef SA; de Bruin A; van Bel F; Kavelaars A; Heijnen CJ Pediatr Res; 2015 Nov; 78(5):520-6. PubMed ID: 26270577 [TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions. Donega V; Nijboer CH; Braccioli L; Slaper-Cortenbach I; Kavelaars A; van Bel F; Heijnen CJ PLoS One; 2014; 9(11):e112339. PubMed ID: 25396420 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ Brain Behav Immun; 2011 Oct; 25(7):1342-8. PubMed ID: 21473911 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. van Velthoven CT; Kavelaars A; Heijnen CJ Pediatr Res; 2012 Apr; 71(4 Pt 2):474-81. PubMed ID: 22430383 [TBL] [Abstract][Full Text] [Related]
9. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. Donega V; van Velthoven CT; Nijboer CH; van Bel F; Kas MJ; Kavelaars A; Heijnen CJ PLoS One; 2013; 8(1):e51253. PubMed ID: 23300948 [TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cells Expressing bFGF Reduce Brain Damage and Restore Sensorimotor Function after Neonatal Hypoxia-Ischemia. Ye Q; Wu Y; Wu J; Zou S; Al-Zaazaai AA; Zhang H; Shi H; Xie L; Liu Y; Xu K; He H; Zhang F; Ji Y; He Y; Xiao J Cell Physiol Biochem; 2018; 45(1):108-118. PubMed ID: 29316558 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Lee JA; Kim BI; Jo CH; Choi CW; Kim EK; Kim HS; Yoon KS; Choi JH Pediatr Res; 2010 Jan; 67(1):42-6. PubMed ID: 19745781 [TBL] [Abstract][Full Text] [Related]
12. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury. Herz J; Köster C; Reinboth BS; Dzietko M; Hansen W; Sabir H; van Velthoven C; Bendix I; Felderhoff-Müser U Brain Behav Immun; 2018 May; 70():118-130. PubMed ID: 29454023 [TBL] [Abstract][Full Text] [Related]
13. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage. van Velthoven CT; Braccioli L; Willemen HL; Kavelaars A; Heijnen CJ Mol Ther; 2014 Mar; 22(3):645-654. PubMed ID: 24172866 [TBL] [Abstract][Full Text] [Related]
15. Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats. Yang YJ; Wang XL; Yu XH; Wang X; Xie M; Liu CT Undersea Hyperb Med; 2008; 35(2):113-29. PubMed ID: 18500076 [TBL] [Abstract][Full Text] [Related]
16. Improvement of human umbilical cord mesenchymal stem cell transplantation on glial cell and behavioral function in a neonatal model of periventricular white matter damage. Zhu LH; Bai X; Zhang N; Wang SY; Li W; Jiang L Brain Res; 2014 May; 1563():13-21. PubMed ID: 24680746 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. van Velthoven CT; van de Looij Y; Kavelaars A; Zijlstra J; van Bel F; Huppi PS; Sizonenko S; Heijnen CJ Ann Neurol; 2012 Jun; 71(6):785-96. PubMed ID: 22718545 [TBL] [Abstract][Full Text] [Related]
19. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917 [TBL] [Abstract][Full Text] [Related]
20. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Bao X; Wei J; Feng M; Lu S; Li G; Dou W; Ma W; Ma S; An Y; Qin C; Zhao RC; Wang R Brain Res; 2011 Jan; 1367():103-13. PubMed ID: 20977892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]